Evidence map›Paper›PMID 36693763›Full record

ArticleRNA (New York, N.Y.)2023

Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA.

Greta Bagnolini, TinTin B Luu, Amanda E Hargrove

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Greta Bagnolini *Department of Chemistry, Duke University, Durham, North Carolina 27708, USA.ORCID 0000-0001-6237-1235
TinTin B Luu *Department of Chemistry, Duke University, Durham, North Carolina 27708, USA.ORCID 0000-0002-1822-5019
Amanda E HargroveDepartment of Chemistry, Duke University, Durham, North Carolina 27708, USA amanda.hargrove@duke.edu.ORCID 0000-0003-1536-6753

Funding

The Center for HIV RNA Studies (CRNA)U54AI150470 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BIENIASZ, PAUL D. · 2019 to 2021
$15.1M
Harnessing Small Molecules to Probe the Structure and Function of Regulatory RNAsR35GM124785 · NIGMS · DUKE UNIVERSITY · PI HARGROVE, AMANDA E · 2017 to 2023
$2.8M
NIAID NIH HHS U54 AI150470NIGMS NIH HHS R35 GM124785
6 · The paper itself

Abstract

RNA structures regulate a wide range of processes in biology and disease, yet small molecule chemical probes or drugs that can modulate these functions are rare. Machine learning and other computational methods are well poised to fill gaps in knowledge and overcome the inherent challenges in RNA targeting, such as the dynamic nature of RNA and the difficulty of obtaining RNA high-resolution structures. Successful tools to date include principal component analysis, linear discriminate analysis, k-nearest neighbor, artificial neural networks, multiple linear regression, and many others. Employment of these tools has revealed critical factors for selective recognition in RNA:small molecule complexes, predictable differences in RNA- and protein-binding ligands, and quantitative structure activity relationships that allow the rational design of small molecules for a given RNA target. Herein we present our perspective on the value of using machine learning and other computation methods to advance RNA:small molecule targeting, including select examples and their validation as well as necessary and promising future directions that will be key to accelerate discoveries in this important field.

Indexed as

Machine LearningRNANeural Networks, ComputerRNAcheminformaticsmachine learningpattern recognitionquantitative structure activity relationshipsRNAsmall molecule

Identifiers

PMID36693763
PMCPMC10019373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.